Kudos Laboratories India to commercialize Anti-Diabetic Drug ‘Ayush-82’

Q.  Which lab has been asked to commercialize Anti-Diabetic Drug ‘Ayush-82’?
- Published on 17 Mar 16

a. GlaxoSmith
b. Abott laboratories
c. Dr. Reddy
d. Kudos laboratories

ANSWER: Kudos laboratories
 
  • The National Research Development Corporation (NRDC) of the Department of Scientific & Industrial Research, Ministry of Science & Technology signed a License Agreement with Kudos Laboratories India for commercialization of Ayush-82, an Ayurvedic formulation for prevention and management of Diabetes.
  • It has been developed by Central Council for Research in Ayurvedic Sciences (CCRAS), New Delhi, an apex organization for research in Ayurveda under the Ministry of AYUSH (Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homeopathy).
  • Now Kudos Laboratories India could commercialize this product under their trade name.

Related Content

➨ Post your comment / Share knowledge


Enter the code shown above:

(Note: If you cannot read the numbers in the above image, reload the page to generate a new one.)
▲